Fed. Circ. Nixes Inventor's Anti-Coagulant Patent App

Law360, New York (April 19, 2012, 6:57 PM EDT) -- The Federal Circuit rejected a challenge Thursday to a U.S. Patent and Trademark Office decision that sustained the invalidity of an application for a patent covering segments of the heparin molecule designed to stymie blood vessel growth in tumors.

A three-judge panel shot down inventor Shaker A. Mousa's challenge to a Board of Patent Appeals and Interferences ruling that said the heparin fractions disclosed in the application were the same or substantially the same as the heparin fractions taught by a patent issued in 1988....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.